Cosmos Week
Researchers design bone marrow-on-a-chip model to study human immune cells
CosmologyEnglish editionInstitutional sourceInstitutional update

Researchers design bone marrow-on-a-chip model to study human immune cells

Miniaturized model provides window into production and behavior of long-lived antibody-producing cells. in NIH-funded study. .

Original source cited and editorially framed by Cosmos Week. NIH News Releases
Editorial signatureCosmos Week Editorial Desk
Published12 Sep 2026 17: 47 UTC
Updated2026-09-12
Coverage typeInstitutional source
Evidence levelInstitutional update
Read time4 min read

Key points

  • Focus: Miniaturized model provides window into production and behavior of long-lived antibody-producing cells
  • Detail: separate announcement from evidence
  • Editorial reading: institutional release, useful as a primary source but not independent validation.
Full story

Miniaturized model provides window into production and behavior of long-lived antibody-producing cells. in NIH-funded study. The institutional report frames the development in practical terms and ties it to the broader mission or observing effort.

The significance lies in cosmology operates at the edge of what current instruments can measure, where systematic errors and model assumptions are never trivial. Small discrepancies between independent measurements have historically pointed toward missing physics rather than simple calibration errors, and the ongoing tension in the Hubble constant is a live example of how a persistent disagreement between methods can reshape the theoretical landscape. Each new dataset that approaches this territory with independent systematics adds real information to a problem that has resisted easy resolution for more than a decade. Miniaturized model provides window into production and behavior of long-lived antibody-producing cells in NIH-funded study. A scientific team funded by the National Institutes of Health (NIH) has developed a laboratory model that reveals how antibody-producing plasma cells migrate, mature, and survive.

Analysis of the cells in the tissue chip provides essential new information that advances our understanding of plasma cell development and function. This model also supports testing of new therapies for infection prevention, inhibition of allergy, and reduction of autoimmunity.

The study was published in Science Advances. Powers III, M. D, acting director of NIH’s National Institute of Allergy and Infectious Diseases (NIAID).

However, we are trying to mimic the structure, fundamental biological functions, and spatial microenvironments to ask questions about human organ-like behavior in this more. This research was funded in part by NIAID under R01AI186314 and R01AI181282 and by the National Institute of General Medical Sciences (NIGMS) grant T32GM145735.

The relevance goes beyond one dataset because even small shifts in measured parameters can matter when the field is testing the limits of the standard cosmological model. The Lambda-CDM framework describes the observable universe with remarkable economy, but its success rests on two components, dark matter and dark energy, whose physical nature remains entirely unknown. Any credible measurement that tightens or loosens the constraints on those components moves the entire theoretical enterprise forward, regardless of whether the immediate result looks dramatic on its own terms.

NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both. For more information about NIH and its programs, visit www. nih. gov.

Because the account originates with NIH News Releases, it functions best as a primary institutional report that is close to the data and operations, not as independent scientific validation. Institutional communications are produced by organizations with legitimate interests in presenting their work in a favorable light, which does not make them unreliable but does make them partial. Details that complicate the narrative, including instrument limitations, unexpected failures and results below projections, tend to be minimized relative to progress messages. Technical documentation and peer-reviewed publications, where they exist, provide the complementary layer that institutional releases cannot substitute.

The next step is to see whether the effect survives when independent surveys, different calibration strategies and tighter control of systematic uncertainties enter the picture. Programmes such as Euclid, DESI and the Rubin Observatory will deliver datasets over the next several years that cover the same parameter space with largely independent methods. If the current signal persists through those tests, its theoretical implications will become impossible to set aside.

Source